Overview

Safety and Efficacy of Novel Combination Regimens for Treatment of Onchocerciasis

Status:
Not yet recruiting
Trial end date:
2026-07-01
Target enrollment:
Participant gender:
Summary
This study will investigate the safety and effectiveness of combination regimens in persons with onchocerciasis when it is administered after pre-treatment with ivermectin to clear or greatly reduce microfilariae from the skin and eyes.
Phase:
Phase 2
Details
Lead Sponsor:
Washington University School of Medicine
Collaborator:
National Public Health Institute of Liberia
Treatments:
Albendazole
Diethylcarbamazine
Ivermectin
Moxidectin